Partnership Will Harness NYSCF’s Automated Cell Culture Systems and Artificial Intelligence Capabilities to Study Disease at an Unprecedented Cellular Level NEW YORK, NY (January 10, 2025)...
Largest collection of patient stem cell models of multiple sclerosis to date uncovers novel disease insights and opens the door for new treatments NEW YORK, NY...
The International Society for Stem Cell Research (ISSCR) recently announced its 2024 award recipients, with NYSCF – Robertson Stem Cell Investigator Jun Wu, PhD, of UT...
The Context: Brain organoids – 3D avatars of human brain tissue made from stem cells – are a revolutionary tool for studying disease. However, it has...
If you picture where brain disease research takes place, you might conjure an image of a laboratory full of white-coated scientists tinkering with microscopes and pipettes....
The Context: Why is it that sometimes you feel a desperate need for a salty snack, and other times you can’t think of anything worse? Your...
The Context: Glia – the brain’s helper cells – are often overlooked in disease research, but are known to play both supportive roles for neurons, and...
NYSCF – Robertson Stem Cell Investigator Alumnus Paul Tesar, DPhil, and NYSCF – Druckenmiller Fellow Marissa Scavuzzo, PhD, of Case Western Reserve University are determined to...
The New York Stem Cell Foundation’s (NYSCF) 18th Annual Conference convenes global leaders in stem cell research to present their latest progress towards treatments and cures...
The Context: Roughly 50 million Americans experience chronic pain (persistent or recurrent pain lasting longer than 3 months), but we do not have adequate methods for...
This May, we gathered once again in beautiful Montauk for the NYSCF Innovator Retreat, in the 13th installment of an annual meeting where the NYSCF –...
The Context: Octopus and squid tentacles are home to a complex nervous system that lets them sense their external environments, even being able to taste what...
The Context: INAD is a rare neurological disease affecting children, often referred to as a “pediatric Parkinson’s,” which is typically diagnosed between six months to three...
The Context: Turning patient stem cells into the different cell types of the brain offers immense promise for studying and treating neurodegenerative diseases such as Alzheimer’s,...
As NYSCF enters 2023, we’re taking a moment to look back at the defining moments of 2022. Whether it was gathering in person again for our...
The Context: As we listen to the world around us, our brains can tell us when something doesn’t sound right – i.e. the wrong music note,...
The Context: We don’t need to tell you that the world is a stressful place – and everyone will have to overcome extreme challenges at some...
The Context: Neuropsychiatric disorders are notoriously hard to study due to their complexity and the inaccessibility of human brain tissue for experimentation. However, recent advances in...
First induced pluripotent stem cell model of PTSD offers insights into underlying genetics and opportunities for new therapies (Sign up for our upcoming webinar on November...
The Context: Post-traumatic stress disorder (PTSD) affects more than 12 million people worldwide. Only a minority of people exposed to trauma will end up with PTSD,...
The New York Stem Cell Foundation’s (NYSCF) 16th Annual Conference convenes global leaders in stem cell research to present their latest progress towards treatments and cures...
Spencer Haws might be relatively new to the field of stem cells, but he’s diving in head first to understand a disease with few treatment options:...
Most people know Paola Arlotta, PhD, Professor and Chair of the Department of Stem Cell and Regenerative Biology at Harvard University, for her seminal contributions to...
The Context: Associating memories with good and bad feelings is something we do daily without a second thought. However, scientists have been working hard to discern...
The Context: The major hallmark of Parkinson’s disease is an accumulation of a protein in the brain called alpha-synuclein. While alpha-synuclein has been the focal point...
